Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sign in
Join now
Deepak Bhatt MD, MPH, FACC, FAHA, FESC, MSCAI
Deepak L. Bhatt MD, MPH, FACC, FAHA, FESC, MSCAI Advisory Board
Peter Libby MD
Peter Libby MD Advisory Board
Douglas Zipes MD
Douglas P. Zipes MD Editor-in-Chief
See All Experts
featured
Published in Cardiology

Expert Opinion / Commentary · December 04, 2022

2022 Top Story in Cardiology: Heart Failure With Preserved Systolic Function

Ileana Piña MD, MPH, FAHA, FACC

 

 Save  Recommend
 Share

Additional Info

  1. Fonarow GC, Corday E. Overview of Acutely Decompensated Congestive Heart Failure (ADHF): A Report From the ADHERE Registry. Heart Fail Rev. 2004l;9(3):179-185.
  2. Massie BM, Carson PE, McMurray JJ, et al. Irbesartan in Patients With Heart Failure and Preserved Ejection Fraction. N Engl J Med. 2008;359(23):2456-2467.
  3. Pitt B, Pfeffer MA, Assmann SF, et al. Spironolactone for Heart Failure With Preserved Ejection Fraction. N Engl J Med. 2014;370(15):1383-1392.
  4. Yusuf S, Pfeffer MA, Swedberg K, et al. Effects of Candesartan in Patients With Chronic Heart Failure and Preserved Left-Ventricular Ejection Fraction: The CHARM-Preserved Trial. Lancet. 2003;362(9386):777-781.
  5. Yancy CW, Jessup M, Bozkurt B, et al. 2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America. J Am Coll Cardiol. 2017;70(6):776-803.
  6. Packer M, Anker SD, Butler J, et al. Cardiovascular and Renal Outcomes With Empagliflozin in Heart Failure. N Engl J Med. 2020;383(15):1413-1424.
  7. Anker SD, Butler J, Filippatos G, et al. Empagliflozin in Heart Failure With a Preserved Ejection Fraction. N Engl J Med. 2021;385(16):1451-1461.
  8. Heidenreich PA, Bozkurt B, Aguilar D, et al. 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2022;145(18):e895-e1032.

Disclosure statements are available on the authors' profiles:

Ileana Piña MD, MPH, FAHA, FACC

Further Reading

Most Read This Week

Recently Updated